News

For the 2025 outlook, Novo Nordisk now expects 13-21% revenue increase at constant exchange rates (CER). Operating profit is ...
GlobalData analysis predicts the global GLP-1RA market will reach $168bn by 2033, with Novo Nordisk and Eli Lilly to dominate ...
IT ONCE boasted over five million subscribers and saw one million of us stepping onto the scales every year. But Weight ...
Cosmetic Dermatology & MediSpa of NJ, a leading cosmetic dermatology center in New Jersey (with locations in Englewood, Wayne, and Newark), proudly announces a notable increase in demand for BodyTite, ...
A leading obesity doctor has said a new trial of weight loss drugs Mounjaro and Wegovy may lead advertisers to reconsider their prices.
The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...
Both medications were prescribed as weekly injections for patients clinically classified as obese, and were recommended ...
Meghan Trainor changed a certain lyric in "All About That Bass" during a May 10 performance in Huntington Beach, Calif.
WGN’s Dina Bair has the latest on new medical information, including: Study: Mounjaro helped people achieve more weight loss ...
In a nutshell Tirzepatide (Mounjaro) produced 20.2% weight loss compared to semaglutide’s (Wegovy) 13.7% after 72 weeks of ...
Tirzepatide slashed weight by 20%, leading researchers to call this a new “golden age” for weight-loss therapies.
Weight loss drugs and jabs have become more popular and a recent study looked at the effectiveness of two drugs ...